These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29414039)

  • 21. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
    Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
    BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FoxM1-mediated RFC5 expression promotes temozolomide resistance.
    Peng WX; Han X; Zhang CL; Ge L; Du FY; Jin J; Gong AH
    Cell Biol Toxicol; 2017 Dec; 33(6):527-537. PubMed ID: 28185110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted Degradation.
    Luo G; Lin X; Vega-Medina A; Xiao M; Li G; Wei H; Velázquez-Martínez CA; Xiang H
    J Med Chem; 2021 Dec; 64(23):17098-17114. PubMed ID: 34812040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiostrepton, proteasome inhibitors and FOXM1.
    Gartel AL
    Cell Cycle; 2011 Dec; 10(24):4341-2. PubMed ID: 22134246
    [No Abstract]   [Full Text] [Related]  

  • 26. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic Insights into the Preference for Tandem Binding Sites in DNA Recognition by FOXM1.
    Zhang H; Dai S; Liang X; Li J; Chen Y
    J Mol Biol; 2022 Mar; 434(5):167426. PubMed ID: 34973238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting FOXM1 in cancer.
    Halasi M; Gartel AL
    Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational identification of natural organic compounds to target the intermolecular interaction between Foxm and DNA in colorectal cancer.
    Dong C; Yan P; Wang J; Mu H; Wang S; Guo F
    Bioorg Chem; 2017 Feb; 70():12-16. PubMed ID: 27881238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition.
    Fang P; Madden JA; Neums L; Moulder RK; Forrest ML; Chien J
    Mol Cancer Res; 2018 Jun; 16(6):961-973. PubMed ID: 29545475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
    Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
    Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
    Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there potential to target FOXM1 for 'undruggable' lung cancers?
    Kalinichenko VV; Kalin TV
    Expert Opin Ther Targets; 2015 Jul; 19(7):865-7. PubMed ID: 25936405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antineoplastic activity of ethylene glycol phenyl aminoethyl ether derivatives as FOXM1 inhibitors.
    Gao Y; Geng J; Xie Z; Zhou Z; Yang H; Yi H; Han X; Xue S; Li Z
    Eur J Med Chem; 2022 Dec; 244():114877. PubMed ID: 36334454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2D-QSAR study, molecular docking, and molecular dynamics simulation studies of interaction mechanism between inhibitors and transforming growth factor-beta receptor I (ALK5).
    Jiang MN; Zhou XP; Sun DR; Gao H; Zheng QC; Zhang HX; Liang D
    J Biomol Struct Dyn; 2018 Nov; 36(14):3705-3717. PubMed ID: 29064324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.
    Liu LL; Zhang DH; Mao X; Zhang XH; Zhang B
    Biochem Biophys Res Commun; 2014 Mar; 446(1):280-5. PubMed ID: 24582753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.